Canadian Medical Association Journal, Vol 160, Issue 4 483-488, Copyright © 1999 by Canadian Medical Association

Research * Recherche

The cost of obesity in Canada

C. L. Birmingham, J. L. Muller, A. Palepu, J. J. Spinelli and A. H. Anis

BACKGROUND: Almost one-third of adult Canadians are at increased risk of disability, disease and premature death because of being obese. In order to allocate limited health care resources rationally, it is necessary to elucidate the economic burden of obesity. OBJECTIVE: To estimate the direct costs related to the treatment of and research into obesity in Canada in 1997. METHODS: The prevalence of obesity (body mass index of 27 or greater) in Canada was determined using data from the National Population Health Survey, 1994-1995. Ten comorbidities of obesity were identified from the medical literature. A population attributable fraction (PAF) was calculated for each comorbidity with data from large cohort studies to determine the extent to which each comorbidity and its management costs were attributable to obesity. The direct cost of each comorbidity was determined using data from the Canadian Institute of Health Information (for direct expenditure categories) and from Health Canada (for the proportion of expenditure category attributable to the comorbidity). This prevalence-based approach identified the direct costs of hospital care, physician services, services of other health professionals, drugs, other health care and health research. For each comorbidity, the cost attributable to obesity was determined by multiplying the PAF by the total direct cost of the comorbidity. The overall impact of obesity was estimated as the sum of the PAF-weighted costs of treating the comorbidities. A sensitivity analysis was completed on both the estimated costs and the PAFs. RESULTS: The total direct cost of obesity in Canada in 1997 was estimated to be over $1.8 billion. This corresponded to 2.4% of the total health care expenditures for all diseases in Canada in 1997. The sensitivity analysis revealed that the total cost could be as high as $3.5 billion or as low as $829.4 million; this corresponded to 4.6% and 1.1% respectively of the total health care expenditures in 1997. When the contributions of the comorbidities to the total cost were considered, the 3 largest contributors were hypertension ($656.6 million), type 2 diabetes mellitus ($423.2 million) and coronary artery disease ($346.0 million). INTERPRETATION: A considerable proportion of health care dollars is devoted to the treatment and management of obesity-related comorbidities in Canada. Further research into the therapeutic benefits and cost-effectiveness of management strategies for obesity is required. It is anticipated that the prevention and treatment of obesity will have major positive effects on the overall cost of health care.

This article has been cited by other articles:

				G. Cochrane Role for a sense of self-worth in weight-loss treatments: Helping patients develop self-efficacy Can Fam Physician, April 1, 2008; 54(4): 543 - 547. [Abstract] [Full Text] [PDF]

				K. Nakamura, T. Okamura, H. Kanda, T. Hayakawa, A. Okayama, H. Ueshima, and The Health Promotion Research Committee of the Shi Medical costs of obese Japanese: a 10-year follow-up study of National Health Insurance in Shiga, Japan Eur J Public Health, October 1, 2007; 17(5): 424 - 429. [Abstract] [Full Text] [PDF]

				M. He and A. Evans Are parents aware that their children are overweight or obese?: Do they care? Can Fam Physician, September 1, 2007; 53(9): 1493 - 1499. [Abstract] [Full Text] [PDF]

				D. C.W. Lau, J. D. Douketis, K. M. Morrison, I. M. Hramiak, A. M. Sharma, E. Ur, and for members of the Obesity Canada Clinical Practic 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary] Can. Med. Assoc. J., April 10, 2007; 176(8): S1 - S13. [Full Text] [PDF]

				D. C.W. Lau, J. D. Douketis, K. M. Morrison, I. M. Hramiak, A. M. Sharma, E. Ur, and pour les membres du Groupe d'experts d'Obesite Can Lignes directrices canadiennes de 2006 sur la prise en charge et la prevention de l'obesite chez les adultes et les enfants [sommaire] Can. Med. Assoc. J., April 10, 2007; 176(8): SF1 - SF14. [Full Text] [PDF]

				M. A. Stefan, W. M. Hopman, and J. F. Smythe Effect of Activity Restriction Owing to Heart Disease on Obesity Arch Pediatr Adolesc Med, May 1, 2005; 159(5): 477 - 481. [Abstract] [Full Text] [PDF]

				J. B. Dixon, W. J. Pories, P. E. O'Brien, P. R. Schauer, and P. Zimmet Surgery as an Effective Early Intervention for Diabesity: Why the reluctance? Diabetes Care, February 1, 2005; 28(2): 472 - 474. [Full Text] [PDF]

				H. J Petrie, S. E Chown, L. M Belfie, A. M Duncan, D. H McLaren, J. A Conquer, and T. E Graham Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss Am. J. Clinical Nutrition, July 1, 2004; 80(1): 22 - 28. [Abstract] [Full Text] [PDF]

				K. A. Meckling, C. O'Sullivan, and D. Saari Comparison of a Low-Fat Diet to a Low-Carbohydrate Diet on Weight Loss, Body Composition, and Risk Factors for Diabetes and Cardiovascular Disease in Free-Living, Overweight Men and Women J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2717 - 2723. [Abstract] [Full Text] [PDF]

				J. E. Manson, P. J. Skerrett, P. Greenland, and T. B. VanItallie The Escalating Pandemics of Obesity and Sedentary Lifestyle: A Call to Action for Clinicians Arch Intern Med, February 9, 2004; 164(3): 249 - 258. [Abstract] [Full Text] [PDF]

				S. Y. Pan, K. C. Johnson, A.-M. Ugnat, S. W. Wen, and Y. Mao Association of Obesity and Cancer Risk in Canada Am. J. Epidemiol., February 1, 2004; 159(3): 259 - 268. [Abstract] [Full Text] [PDF]

				W. M. Goldstein, J. J. Branson, K. A. Berland, and A. C. Gordon Minimal-Incision Total Hip Arthroplasty J. Bone Joint Surg. Am., November 1, 2003; 85(90004): 33 - 38. [Full Text] [PDF]

				G. F. Dervin, I. G. Stiell, K. Rody, and J. Grabowski Effect of Arthroscopic Débridement for Osteoarthritis of the Knee on Health-Related Quality of Life J. Bone Joint Surg. Am., January 17, 2003; 85(1): 10 - 19. [Abstract] [Full Text] [PDF]

				K. Narbro, G. Agren, E. Jonsson, I. Naslund, L. Sjostrom, and M. Peltonen Pharmaceutical Costs in Obese Individuals: Comparison With a Randomly Selected Population Sample and Long-term Changes After Conventional and Surgical Treatment: The SOS Intervention Study Arch Intern Med, October 14, 2002; 162(18): 2061 - 2069. [Abstract] [Full Text] [PDF]

				P. T. Katzmarzyk The Canadian obesity epidemic, 1985-1998 Can. Med. Assoc. J., April 1, 2002; 166(8): 1039 - 1040. [Full Text] [PDF]

				C. L. Birmingham and P. J. Jones Clinical nutrition: 5. How much should Canadians eat? Can. Med. Assoc. J., March 1, 2002; 166(6): 767 - 770. [Full Text] [PDF]

				G. Berg, K. Delaive, J. Manfreda, R. Walld, and M. H. Kryger The Use of Health-Care Resources in Obesity-Hypoventilation Syndrome Chest, August 1, 2001; 120(2): 377 - 383. [Abstract] [Full Text] [PDF]

				P. T. Katzmarzyk, N. Gledhill, and R. J. Shephard The economic burden of physical inactivity in Canada Can. Med. Assoc. J., November 1, 2000; 163(11): 1435 - 1440. [Abstract] [Full Text] [PDF]

				J. Hoey When editors publish in their own journals Can. Med. Assoc. J., November 1, 1999; 161(11): 1412 - 1413. [Full Text] [PDF]

HOME	CURRENT ISSUE	PAST ISSUES	COLLECTIONS	HELP	SEARCH
Copyright 1995-1999, Canadian Medical Association. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p) All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.